glutathione and dystonia S-transferase: A keystone in Parkinson's disease pathogenesis therapy Frontiers | Glutathione and neurodegenerative

Combination Approaches Future treatments might combine incretin agonists with other weight loss mechanisms like metabolism boosters, appetite suppressants working through non-incretin pathways, or fat absorption inhibitors

Extracellular vesicles in cancers: mechanisms, biomarkers, and therapeutic strategies

Glutathione signaling helps control reactive oxygen species (ROS), which can damage the body and kill cells

How will you classify Glucose-6-phosphate Dehydrogenase (G6PD)

Since the peptides have a short half-life because of their small size, they can easily get degraded by the enzymes present inside the human body and filtered out by the kidneys